
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tafolecimab, A Novel Member of PCSK9 Monoclonal Antibodies, Is Worth Expecting in a Chinese Population
Jian‐Jun Li
JACC Asia (2023) Vol. 3, Iss. 4, pp. 646-648
Open Access | Times Cited: 6
Jian‐Jun Li
JACC Asia (2023) Vol. 3, Iss. 4, pp. 646-648
Open Access | Times Cited: 6
Showing 6 citing articles:
Drug development advances in human genetics‐based targets
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 8
X. Zhang, Wenjun Yu, Yan Li, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 8
Emerging clinical role of proprotein convertase subtilisin/kexin type 9 inhibition–Part two: Current and emerging concepts in the clinical use of PCSK9 inhibition
Alexander M. Cao Zhang, Efthymios Ziogos, Tarek Harb, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Closed Access | Times Cited: 5
Alexander M. Cao Zhang, Efthymios Ziogos, Tarek Harb, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 10
Closed Access | Times Cited: 5
Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives
Pratiksha Jamadade, Neh Nupur, Krushna Ch Maharana, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 10, pp. 549-571
Closed Access | Times Cited: 5
Pratiksha Jamadade, Neh Nupur, Krushna Ch Maharana, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 10, pp. 549-571
Closed Access | Times Cited: 5
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review
Huihui Liu, Sha Li, Jian‐Jun Li
Drugs (2025)
Closed Access
Huihui Liu, Sha Li, Jian‐Jun Li
Drugs (2025)
Closed Access
Tafolecimab: First Approval
Susan J. Keam
Drugs (2023) Vol. 83, Iss. 16, pp. 1545-1549
Closed Access | Times Cited: 10
Susan J. Keam
Drugs (2023) Vol. 83, Iss. 16, pp. 1545-1549
Closed Access | Times Cited: 10
Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies
Zaheer Qureshi, Mikail Khanzada, Adnan Safi, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 2
Zaheer Qureshi, Mikail Khanzada, Adnan Safi, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 2